Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare · Drug Manufacturers - General
Bristol-Myers Squibb Company is a Healthcare company with a market capitalization of $131.77B, a trailing P/E ratio of 14.2, and a dividend yield of 2.91%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $1.58 | $1.42 | +11.3% |
| Q4 2025 | February 5, 2026 | $1.26 | $1.20 | +5.0% |
| Q3 2025 | October 30, 2025 | $1.63 | $1.52 | +7.2% |
| Q2 2025 | July 31, 2025 | $1.46 | $1.10 | +32.7% |
| Q1 2025 | April 24, 2025 | $1.80 | $1.50 | +20.0% |
| Q4 2024 | February 6, 2025 | $1.67 | $1.47 | +13.6% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 44,935,362 | 2.20% | 4.2 | +10.9% |
| June 30, 2026 | 40,531,289 | 1.98% | 2.5 | +2.4% |
| June 15, 2026 | 39,595,308 | 1.94% | 3.3 | +2.8% |
| May 29, 2026 | 38,507,952 | 1.88% | 3.5 | +4.9% |
| May 15, 2026 | 36,716,099 | 1.80% | 3.5 | +17.2% |
| April 30, 2026 | 31,330,595 | 1.53% | 3.2 | -3.3% |
| April 15, 2026 | 32,393,759 | 1.59% | 3.4 | +2.8% |
| March 31, 2026 | 31,501,585 | 1.54% | 2.0 | +5.5% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Bristol-Myers Squibb Company's market cap?
As of August 13, 2026, Bristol-Myers Squibb Company (BMY) has a market capitalization of $131.77B.
What is Bristol-Myers Squibb Company's P/E ratio?
Bristol-Myers Squibb Company trades at a trailing price-to-earnings (P/E) ratio of 14.2. Its forward P/E is 9.4.
Does Bristol-Myers Squibb Company pay a dividend?
Yes — Bristol-Myers Squibb Company pays a dividend yielding 2.91%, an annual payout of $2.51 per share.
What sector is BMY in?
Bristol-Myers Squibb Company is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Bristol-Myers Squibb Company's short interest?
As of the July 15, 2026 FINRA settlement, 44,935,362 BMY shares were sold short, or 2.20% of shares outstanding. Days to cover: 4.2. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Bristol-Myers Squibb Company's revenue?
In its latest reported fiscal year (ending December 31, 2025), Bristol-Myers Squibb Company reported revenue of $48.19B and net income of $7.05B.
Ask your own questions about BMY
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.